Exposure to In Utero Chemotherapy Did Not Affect Children’s Development, Behavior

Article

In this video we discuss two poster presentations on childhood development and behavior after in utero exposure to chemotherapy for maternal cancer in pregnancy.

In this video from the 32nd Annual Miami Breast Cancer Conference, Elyce Cardonick, MD, maternal fetal specialist at the Cooper Health System, discusses two poster presentations on childhood development and behavior after in utero exposure to chemotherapy for maternal cancer in pregnancy.

Recent Videos
Future research will aim to assess the efficacy of PIPAC-MMC plus systemic therapy vs systemic therapy alone in patients with peritoneal tumors.
Although small incision surgery may serve as a conduit to deliver PIPAC-MMC, it may confer benefits in the staging and treatment of peritoneal tumors.
Patients with peritoneal metastases were historically associated with limited survival and low consideration for clinical trials.
Findings from the OVARIO study show that patients with HRR–deficient and BRCA-mutated disease benefitted the most from niraparib/bevacizumab maintenance.
Select comorbidities, ECOG status, and the receipt of radiation were among the differences between a real-world cohort and the RUBY trial population.
Related Content